Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel
Condition(s):Prostate Cancer MetastaticLast Updated:May 12, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Prostate Cancer MetastaticLast Updated:May 12, 2022Completed
Condition(s):Gastrointestinal Stromal Tumor(GIST)Last Updated:January 7, 2020Completed
Condition(s):Hepatitis, Drug-InducedLast Updated:December 14, 2022Recruiting
Condition(s):Prostate CancerLast Updated:February 8, 2021Not yet recruiting
Condition(s):Nasopharyngeal Carcinoma; Adverse Effect of Radiation Therapy; Brain NecrosisLast Updated:January 9, 2019Completed
Condition(s):Lymphoma, FollicularLast Updated:January 29, 2020Completed
Condition(s):Lupus NephritisLast Updated:June 28, 2011Completed
Condition(s):Congenital Adrenal HyperplasiaLast Updated:April 8, 2022Withdrawn
Condition(s):Pneumocystis; HIV/AIDS; SteroidLast Updated:February 8, 2024Enrolling by invitation
Condition(s):Sarcoidosis, PulmonaryLast Updated:March 12, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.